In vivo drug efficacy studies
Studies cover central nervous system, cardiovascular and metabolic disease, respiratory, gastroenterology, and dermatology.
Source: LinkedIn company description · Retrieved October 13, 2026
Syncrosome is a preclinical contract research organization focused on in vivo efficacy studies.
The company has developed and validated more than 15 disease models.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Syncrosome assists drug discovery companies in selecting compounds.
Studies cover central nervous system, cardiovascular and metabolic disease, respiratory, gastroenterology, and dermatology.
Source: LinkedIn company description · Retrieved October 13, 2026
These studies focus on blood-brain barrier passage and/or neurotransmitter monitoring.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: October 8, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 16, 2026, September 18, 2026, September 19, 2026, September 28, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.